KYOUNGMI SONG: Open Payments
NPI 1770252991 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$898 in 41 payments from 18 companies in 2025. Trend: 2023 $675 · 2024 $792 · 2025 $898
Food & beverage: $898
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 10 | $215 |
| Lilly USA, LLC | 5 | $108 |
| Abbott Laboratories | 4 | $82 |
| SANOFI-AVENTIS U.S. LLC | 2 | $68 |
| Radius Health, Inc. | 3 | $67 |
| Xeris Pharmaceuticals, Inc. | 3 | $61 |
| Sequel Med Tech, LLC | 1 | $54 |
| Madrigal Pharmaceuticals | 2 | $42 |
| Amgen Inc. | 2 | $30 |
| Tandem Diabetes Care, Inc. | 1 | $26 |
Products named: Omnipod, FREESTYLE LIBRE 3, TZIELD, Tymlos, MOUNJARO, JARDIANCE, TWIIST, RECORLEV.
Industry payments across NY — which companies pay providers there.
